Guangdong, China

Yingxin Lu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Longuide Biopharma Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yingxin Lu. Retrieved from https://idiyas.com/inventor/yingxin-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Yingxin Lu

Introduction: Yingxin Lu is a prominent inventor based in Guangdong, China, recognized for his significant contributions to the field of biopharmaceuticals. With a focus on lipid nanoparticle formulations, he is making strides in advancing the delivery methods of nucleic acids, including mRNA.

Latest Patents: Yingxin Lu holds a patent for "Lipids and lipid nanoparticle formulations," which details innovative methods for employing lipids and lipid nanoparticles for the effective delivery of nucleic acids. This patent reflects a growing need for efficient drug delivery systems in therapeutic applications.

Career Highlights: Lu has made remarkable strides in his career, especially through his affiliation with Longuide Biopharma Corporation. His work has positioned him as a key player in the development of advanced biopharmaceutical technologies.

Collaborations: Yingxin Lu collaborates with notable colleagues, including Longgui Zhang and Yuebao Zhang, to drive innovative research and development efforts in their projects. Their teamwork fosters a dynamic environment for creating impactful solutions in the biopharmaceutical sector.

Conclusion: Yingxin Lu is a trailblazer in the field of lipid-based drug delivery systems, with a patent that underscores his commitment to innovation. Through his contributions at Longuide Biopharma Corporation and collaborations with his peers, Lu continues to shape the future of biopharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…